164 related articles for article (PubMed ID: 34622843)
41. Anterior ischemic optic neuropathy associated with Vogt-Koyanagi-Harada disease.
Nakao K; Mizushima Y; Abematsu N; Goh N; Sakamoto T
Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1417-25. PubMed ID: 19568763
[TBL] [Abstract][Full Text] [Related]
42. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
Manethova K; Ernest J; Hrevus M
Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
[TBL] [Abstract][Full Text] [Related]
43. Development of Acute Vogt-Koyanagi-Harada-like Syndrome during the Treatment Course with Vemurafenib for Metastatic Melanoma.
Apivatthakakul A; Kunavisarut P; Rothova A; Pathanapitoon K
Ocul Immunol Inflamm; 2020 Apr; 28(3):505-508. PubMed ID: 31161956
[No Abstract] [Full Text] [Related]
44. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Maruyama Y; Kishi S
Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy.
Takayama K; Obata H; Takeuchi M
Ocul Immunol Inflamm; 2020 Apr; 28(3):509-512. PubMed ID: 31268769
[No Abstract] [Full Text] [Related]
46. Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.
Shin WB; Kim MK; Lee CS; Lee SC; Kim H
Korean J Ophthalmol; 2015 Dec; 29(6):389-95. PubMed ID: 26635455
[TBL] [Abstract][Full Text] [Related]
47. Clinical relevance of fibrin membranous structures in the intra-photoreceptor outer segment separation on spectral domain optical coherence tomography (SD-OCT) in initial-onset acute Vogt-Koyanagi-Harada disease.
Motegi S; Nagura K; Yoneda K; Harimoto K; Sato T; Herbort CP; Takeuchi M
Acta Ophthalmol; 2023 May; 101(3):e286-e293. PubMed ID: 36217824
[TBL] [Abstract][Full Text] [Related]
48. Retinal Pigment Epithelium Detachment in Acute Vogt-Koyanagi-Harada Disease: An Unusual Finding at Presentation.
Khochtali S; Ksiaa I; Megzari K; Khairallah M
Ocul Immunol Inflamm; 2019; 27(4):591-594. PubMed ID: 29513616
[No Abstract] [Full Text] [Related]
49. FLUOCINOLONE ACETONIDE IMPLANT FOR VOGT-KOYANAGI-HARADA DISEASE: Three-Year Outcomes of Efficacy and Safety.
Heo JW; Cho BJ; Goldstein DA; Sepah YJ; Do DV; Nguyen QD
Retina; 2016 Nov; 36(11):2124-2131. PubMed ID: 27333235
[TBL] [Abstract][Full Text] [Related]
50. Outcome of Intravitreal Dexamethasone Implant Use in Uveitic Eyes Undergoing Pars Plana Vitrectomy Surgery.
Kirkland KA; Uwaydat SH; Siddiqui MZ; Chancellor JR; Soliman MK; Kurup S; Sallam AB
Ocul Immunol Inflamm; 2021 Aug; 29(6):1126-1131. PubMed ID: 32142385
[No Abstract] [Full Text] [Related]
51. Vogt-Koyanagi-Harada syndrome in a Greenlandic Inuit.
Ostergaard J; Goldschmidt E; Andersen N
Acta Ophthalmol; 2008 Aug; 86(5):576-8. PubMed ID: 18039349
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies.
Shen E; Rathinam SR; Babu M; Kanakath A; Thundikandy R; Lee SM; Browne EN; Porco TC; Acharya NR
Am J Ophthalmol; 2016 Aug; 168():279-286. PubMed ID: 27296490
[TBL] [Abstract][Full Text] [Related]
53. The effect of pulse steroid treatment of ten days' long on the improvement of bacillary layer detachment in a patient with Vogt-Koyanagi Harada disease.
Atas F; Kaya M; Saatci AO
Rom J Ophthalmol; 2021; 65(2):183-186. PubMed ID: 34179585
[No Abstract] [Full Text] [Related]
54. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
55. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
[TBL] [Abstract][Full Text] [Related]
56. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
[TBL] [Abstract][Full Text] [Related]
57. Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography.
Yamamoto M; Nishijima K; Nakamura M; Yoshimura N
Jpn J Ophthalmol; 2011 Jan; 55(1):1-6. PubMed ID: 21331684
[TBL] [Abstract][Full Text] [Related]
58. A case of Vogt-Koyanagi-Harada disease in a patient with Graves disease.
Seo JH; Yu HG; Chung H
Korean J Ophthalmol; 2009 Jun; 23(2):112-3. PubMed ID: 19568361
[TBL] [Abstract][Full Text] [Related]
59. Corticotherapy vs. Corticotherapy Plus Immunosuppressive Therapy in Acute Vogt-Koyanagi-Harada Disease.
Concha-Del Río LE; Gómez L; Arellanes-García L
Arch Soc Esp Oftalmol (Engl Ed); 2018 May; 93(5):225-230. PubMed ID: 29258782
[TBL] [Abstract][Full Text] [Related]
60. Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report.
Koyama M; Nishijima E; Honda T; Gonmori-Ohta C; Sasamoto T; Tanaka K; Watanabe A; Nakano T; Akiyama M
BMC Ophthalmol; 2024 Mar; 24(1):115. PubMed ID: 38481205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
